betamethasone has been researched along with flunisolide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Toogood, JH | 1 |
| Gruchelska, B | 1 |
| Sugio, K; Takai, M; Tsurufuji, S | 1 |
2 review(s) available for betamethasone and flunisolide
| Article | Year |
|---|---|
An appraisal of the influence of dose frequency on the antiasthmatic activity of inhaled corticosteroids.
Topics: Administration, Intranasal; Adrenal Cortex Hormones; Asthma; Beclomethasone; Betamethasone; Budesonide; Drug Administration Schedule; Fluocinolone Acetonide; Humans; Pregnenediones; Triamcinolone Acetonide | 1985 |
[Local steroid treatment of allergic diseases of the upper respiratory tract].
Topics: Administration, Intranasal; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Beclomethasone; Betamethasone; Child; Clinical Trials as Topic; Fluocinolone Acetonide; Humans; Middle Aged; Placebos; Research Design; Rhinitis, Allergic, Seasonal | 1982 |
1 trial(s) available for betamethasone and flunisolide
| Article | Year |
|---|---|
[Local steroid treatment of allergic diseases of the upper respiratory tract].
Topics: Administration, Intranasal; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Beclomethasone; Betamethasone; Child; Clinical Trials as Topic; Fluocinolone Acetonide; Humans; Middle Aged; Placebos; Research Design; Rhinitis, Allergic, Seasonal | 1982 |
3 other study(ies) available for betamethasone and flunisolide
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The predominance of flunisolide in the topical use of anti-inflammatory steroids.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Dose-Response Relationship, Drug; Edema; Fluocinolone Acetonide; Glucocorticoids; Male; Mice; Mice, Inbred Strains; Serotonin; Time Factors | 1982 |